CONTROL CAR

Serial Number 87301283
606

Registration Progress

Application Filed
Jan 13, 2017
Under Examination
Jan 2, 2018
Approved for Publication
Nov 7, 2017
Published for Opposition
Nov 7, 2017
Registered

Trademark Image

CONTROL CAR

Basic Information

Serial Number
87301283
Filing Date
January 13, 2017
Published for Opposition
November 7, 2017
Abandonment Date
January 5, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 5, 2021
Classes
042

Rights Holder

Kite Pharma, Inc.

03
Address
2400 Broadway
Santa Monica, CA 90404

Ownership History

Kite Pharma, Inc.

Original Applicant
03
Santa Monica, CA

Kite Pharma, Inc.

Owner at Publication
03
Santa Monica, CA

Legal Representation

Attorney
Christina L. Martini

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Feb 19, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 19, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 14, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 12, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 12, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 12, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 12, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 12, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 12, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
May 6, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 8, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 6, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 6, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 6, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 14, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 12, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 12, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 12, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 18, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 16, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 16, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 5, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 5, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 24, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 22, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
May 22, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 2, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 7, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 7, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 18, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 29, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 30, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 30, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 25, 2017 ALIE A ASSIGNED TO LIE Loading...
Aug 7, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 7, 2017 CPRA R PRIORITY ACTION WRITTEN Loading...
Feb 7, 2017 GPRA F PRIORITY ACTION E-MAILED Loading...
Feb 7, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Jan 30, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 23, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 17, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; medical research, namely, conducting clinical trials for others
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CAR"